SMARCAL1, a chromatin remodeling complex depletion, reduces the sensitivity of tumor cells deficient in BRCA1/2 and causes PARP inhibitor resistance, however, this effect appears to be cell-type specific (Taglialatela et al., 2017; Kolinjivadi et al., 2017). This evidence concerns the gene PARP1 and neoplasm.